It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acinetobacter baumannii is a pathogenic and multidrug-resistant Gram-negative bacterium that causes severe nosocomial infections. To better understand the mechanism of pathogenesis, we compare the proteomes of uninfected and infected human cells, revealing that transcription factor FOS is the host protein most strongly induced by A. baumannii infection. Pharmacological inhibition of FOS reduces the cytotoxicity of A. baumannii in cell-based models, and similar results are also observed in a mouse infection model. A. baumannii outer membrane vesicles (OMVs) are shown to activate the aryl hydrocarbon receptor (AHR) of host cells by inducing the host enzyme tryptophan-2,3-dioxygenase (TDO), producing the ligand kynurenine, which binds AHR. Following ligand binding, AHR is a direct transcriptional activator of the FOS gene. We propose that A. baumannii infection impacts the host tryptophan metabolism and promotes AHR- and FOS-mediated cytotoxicity of infected cells.
In this work, authors study the proteins in uninfected and Acinetobacter baumannii infected human cells to understand how this bacterium causes disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Goethe University, Buchmann Institute for Molecular Life Sciences, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
2 Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
3 Hospital of the Goethe University, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); University Center of Competence for Infection Control of the State of Hesse, Frankfurt, Germany (GRID:grid.7839.5)
4 1 DNA Way, Department of Infectious Diseases, Genentech Inc., South San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718)
5 Goethe University, Institute for Vascular Signalling, Department of Molecular Medicine, CPI, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
6 Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Goethe University, Buchmann Institute for Molecular Life Sciences, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); National Cheng Kung University, Institute of Basic Medical Sciences, College of Medicine, Tainan, Taiwan (GRID:grid.64523.36) (ISNI:0000 0004 0532 3255)
7 Goethe University, Department of Pathology, Dr. Senckenberg Institute of Pathology, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
8 Hospital of the Goethe University, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
9 Goethe University, Institute of Biochemistry II, Faculty of Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Goethe University, Buchmann Institute for Molecular Life Sciences, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Branch Translational Medicine and Pharmacology, Fraunhofer Institute for Molecular Biology and Applied Ecology, Frankfurt, Germany (GRID:grid.418010.c) (ISNI:0000 0004 0573 9904); Max Planck Institute of Biophysics, Frankfurt, Germany (GRID:grid.419494.5) (ISNI:0000 0001 1018 9466)